Technology | Breast Imaging | August 23, 2017

Kubtec Introduces Automatic Specimen Alert to Mozart 3-D Tomosynthesis System

New feature ensures excised tissue is disposed of in a timely manner

Kubtec Introduces Automatic Specimen Alert to Mozart 3-D Tomosynthesis System

August 23, 2017 — Kubtec announced that it has developed a unique solution to a potential problem faced by operating room (OR) staff when treating patients for breast cancer. Automatic Specimen Alert (ASA), now available on the Mozart System, Kubtec’s intraoperative 3-D tomosynthesis system, eliminates the possibility that OR professionals may forget to remove the excised specimen from the system once imaging is complete.

With checklists in place in most ORs, this happens infrequently; but when it does, it can have serious downstream consequences, as the specimen must be fixed in formalin within 60 minutes from the time of excision in order to be considered viable by pathology. Older systems currently in use have a small window through which the technician can see into the specimen chamber. For this to be beneficial, it requires the operator to be close to the instrument and to remember to look inside despite handling many other responsibilities simultaneously.

After 10 minutes of inactivity, the Mozart System’s ASA feature flashes a very clear indication on the system monitor screen if a tissue sample remains inside the cabinet. This allows technicians to see from across the OR that an action is needed.

Automatic Specimen Alert will be available on all Kubtec Cabinet X-ray systems ordered after September 2017.

For more information: www.kubtec.com

Related Content

This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

Flow Chart of Patient Selection

News | Breast Imaging | September 09, 2021
September 9, 202
Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers.

Getty Images | AleksandarNakic

News | Breast Imaging | September 09, 2021
September 9, 2021 — Laws designed to help women with increased risk for...
The researchers say there is currently a lack of good quality evidence to support a policy of replacing human radiologists with artificial intelligence (AI) technology when screening for breast cancer.

Getty Images

News | Artificial Intelligence | September 02, 2021
September 2, 2021 — Humans still seem to be better than technology when it comes to the accuracy of spotting possible
Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy

Schematic overview of cell cycle regulation, with an emphasis on radiotherapy-induced pathways and CDK/cyclin regulation. In M phase and in G2 resting phase, cancer cells are respectively very sensitive and moderately sensitive to radiation injury, whereas in G1 phase and in S phase, cancer cells are moderately resistant to radiation injury. Irradiation induces G1 and G2 cell cycle checkpoint activation and DNA repair. Most cancer cells are defective in G1 checkpoint, commonly due to the mutations/alterations of the key regulators of the G1 checkpoint, but contain a functional G2 checkpoint. Figure courtesy of The International Journal of Molecular Sciences

News | Radiation Therapy | August 18, 2021
August 18, 2021 — Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy t
DenseBreast-info.org (DB-I) announced that the European Society of Radiology (ESR) now links to DB-I website and educational materials as a resource for members about the screening and risk implications of dense breast tissue.
News | Breast Density | August 13, 2021
August 13, 2021 —